this is an important achievement as no drugs are available to overcome cisplatin resistance or kill cisplatin-resistant cells
Per the FDA, compounded drugs that contain DSIP may pose a risk for immunogenicity,26 a state in which the body perceives a substance as a threat and so mounts a potentially life-threatening immune response against it
Schwarz UI, Ritchie MD, Bradford Y, Li C, Dudek SM, Frye-Anderson A, Kim RB, Roden DM, Stein CM
The Hybrid Approach: Some Richmond residents employ both methods strategicallyusing injections to rapidly correct deficiency and restore optimal levels, then maintaining those levels with carefully selected oral supplements between injections
In experimental models of spinal cord damage in rats, early post-injury administration of the peptide was associated with marked improvements in neurological function